Options: Hide MedDRA Preferred Terms , display all 37 labels
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cardiac failure | x | ||||||||||||||||||||||
Cerebrovascular accident | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||
Cough | x | x | |||||||||||||||||||||
Diabetic | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
Diabetic nephropathy | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||||
Essential hypertension | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
Hypersensitivity | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||
Hypertension | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
Hypertensive | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
Left ventricular hypertrophy | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||
Myocardial infarction | x | ||||||||||||||||||||||
Nephropathy | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
Proteinuria | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
Renal failure chronic | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||
Type 2 diabetes mellitus | x | x | x | x | x | x | x | x | x | x | x | x | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |